Get access

Glucose transporter 1 deficiency in the idiopathic generalized epilepsies

Authors

  • Todor Arsov PhD,

    1. Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Australia
    Search for more papers by this author
  • Saul A. Mullen MBBS, PhD,

    1. Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Australia
    2. Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
    Search for more papers by this author
  • Sue Rogers PhD,

    1. St. Vincent's Institute of Medical Research, Fitzroy, Melbourne, Australia
    Search for more papers by this author
  • A. Marie Phillips PhD,

    1. Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
    Search for more papers by this author
  • Kate M. Lawrence BSc,

    1. Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Australia
    Search for more papers by this author
  • John A. Damiano BSc,

    1. Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Australia
    Search for more papers by this author
  • Hadassa Goldberg-Stern MD,

    1. Epilepsy Center, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel
    Search for more papers by this author
  • Zaid Afawi MD,

    1. Department of Neurology, Sourasky Medical Center, Tel Aviv, Israel
    Search for more papers by this author
  • Sara Kivity MD,

    1. Epilepsy Center, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel
    Search for more papers by this author
  • Chantal Trager BSc,

    1. Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
    Search for more papers by this author
  • Steven Petrou PhD,

    1. Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
    2. Centre for Neuroscience, University of Melbourne, Melbourne, Australia
    Search for more papers by this author
  • Samuel F. Berkovic FRS,

    Corresponding author
    1. Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Australia
    • University of Melbourne, Melbourne Brain Centre Building, 245 Burgundy Street, Heidelberg, Victoria 3084, Australia
    Search for more papers by this author
  • Ingrid E. Scheffer MBBS, PhD

    1. Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Australia
    2. Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia
    3. Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Melbourne, Australia
    Search for more papers by this author

Abstract

Objective:

We examined whether glucose transporter 1 (GLUT1) deficiency causes common idiopathic generalized epilepsies (IGEs).

Methods:

The IGEs are common, heritable epilepsies that usually follow complex inheritance; currently little is known about their genetic architecture. Previously considered rare, GLUT1 deficiency, due to mutations in SLC2A1, leads to failure of glucose transport across the blood–brain barrier and inadequate glucose for brain metabolism. GLUT1 deficiency was first associated with an encephalopathy and more recently found in rare dominant families with epilepsy and paroxysmal exertional dyskinesia (PED). Five hundred four probands with IGEs and 470 controls underwent SLC2A1 sequencing. Glucose transport was assayed following expression of SLC2A1 variants in Xenopus oocytes. All available relatives were phenotyped, and SLC2A1 was sequenced.

Results:

Functionally validated mutations in SLC2A1 were present in 7 of 504 (1.4%) probands and 0 of 470 controls. PED, undiagnosed prior to study, occurred in 1 proband and 3 of 13 relatives with mutations. The IGEs in probands and relatives were indistinguishable from typical IGE. Three cases (0.6%) had mutations of large functional effect and showed autosomal dominant inheritance or were de novo. Four (0.8%) cases had a subtle functional effect; 2 showed possible dominant inheritance, and 2 did not. These alleles leading to subtle functional impairment may contribute to complex, polygenic inheritance of IGE.

Interpretation:

SLC2A1 mutations contribute to approximately 1% of IGE both as a dominant gene and as a susceptibility allele in complex inheritance. Diagnosis of GLUT1 deficiency has important treatment (ketogenic diet) and genetic counseling implications. The mechanism of restricted glucose delivery differs from the current focus on IGEs as ion channel disorders. ANN NEUROL 2012;72:807–815

Ancillary